Blog

Media

Potentially promising Alzheimer’s drug going forward

A drug created by the company Biogen might be able to slow the progression of Alzheimer’s Disease.

The company initially discontinued work on aducanumab when it started with disappointing results. They now say that a further analysis of that same data has actually suggested it may decrease cognitive loss in its treatment of Alzheimer’s Disease.

Dr. Andrew Frank speaks with Rob Snow on 580 CFRA

Dr. Andrew Frank of Bruyère spoke about it yesterday on CFRA. Dr. Frank suggests further trials will be necessary, but that this remains a positive development in the world of dementia.

Related Posts

Volunteers Make Waves  Together, we create ripples of change  #VolunteersMakeWaves #NVW2025 Celebrating Volunteer Impact at DSORC The 2025 National Volunteer Week theme—Volunteers Make Waves—honours the[...]
Celebrating the Heart and Soul of The Dementia Society: Our Volunteers In every community, there are individuals whose dedication and hard work often fly under[...]
En 2023, votre soutien a joué un rôle essentiel dans le maintien de la Société de la démence en tant que ressource communautaire accessible et[...]
In 2023, your support played a critical role in maintaining The Dementia Society as an accessible, vital community resource. Thanks to your generosity, thousands of[...]
For Immediate Release Ottawa, ON – September 20, 2023 – The Dementia Society of Ottawa and Renfrew County will be hosting the BrainyActive Walk for[...]
Article
Real-life learning or clinical experience is difficult to get as we emerge from the  pandemic. Many healthcare environments are still operating at reduced levels or under restrictive[...]

DSORC Centre Closure - February 13

Due to severe weather conditions, the DSORC Centre will be closed on Thursday, February 13 and all in-person programs and services will be cancelled. We apologize for any inconvenience.